Protein synthesis inhibitor

Source: Wikipedia, the free encyclopedia.
Simplified schematic of mRNA translation

A protein synthesis inhibitor is a compound that stops or slows the growth or proliferation of cells by disrupting the processes that lead directly to the generation of new

proteins.[1]

RNA into proteins

While a broad interpretation of this definition could be used to describe nearly any compound depending on concentration, in practice, it usually refers to compounds that act at the molecular level on translational machinery (either the ribosome itself or the translation factor),

eukaryotic ribosome structures.[citation needed
]

Mechanism

In general, protein synthesis inhibitors work at different stages of

) and termination:

Earlier stages

Initiation

Ribosome assembly

Aminoacyl tRNA entry

  • aminoacyl tRNAs
    .

Proofreading

  • Aminoglycosides, among other potential mechanisms of action, interfere with the proofreading process, causing increased rate of error in synthesis with premature termination.[7]

Peptidyl transfer

Ribosomal translocation

Termination

  • peptidyl-tRNA
    from the ribosome.
  • Puromycin has a structure similar to that of the tyrosinyl aminoacyl-tRNA. Thus, it binds to the ribosomal A site and participates in peptide bond formation, producing peptidyl-puromycin. However, it does not engage in translocation and quickly dissociates from the ribosome, causing a premature termination of polypeptide synthesis.
  • Streptogramins also cause premature release of the peptide chain.[17]

Protein synthesis inhibitors of unspecified mechanism

Binding site

The following antibiotics bind to the 30S subunit of the ribosome:

The following antibiotics bind to the 50S ribosomal subunit:

See also

References

  1. ^ Frank Lowy. "Protein Synthesis Inhibitors" (PDF). Columbia University. Retrieved 2021-01-27.
  2. ^ "7.344 Antibiotics, Toxins, and Protein Engineering, Spring 2007". MIT OpenCourseWare.
  3. PMID 9835522
    .
  4. .
  5. .
  6. . Retrieved 2009-12-19.
  7. ^ a b Flavio Guzmán (2008-08-12). "Protein synthesis inhibitors: aminoglycosides mechanism of action animation. Classification of agents". Pharmamotion. Archived from the original on 2010-03-12.
  8. ^ a b Protein synthesis inhibitors: macrolides mechanism of action animation. Classification of agents Pharmamotion. Author: Gary Kaiser. The Community College of Baltimore County. Retrieved on July 31, 2009
  9. ^ a b c Page 212 in: Title: Hugo and Russell's pharmaceutical microbiology Authors: William Barry Hugo, Stephen P. Denyer, Norman A. Hodges, Sean P. Gorman Edition: 7, illustrated Publisher: Wiley-Blackwell, 2004 Length: 481 pages
  10. ^ "Geneticin". Thermo Fisher Scientific.
  11. PMID 10318810
    .
  12. ^ Wisteria Lane cases → CLINDAMYCIN Archived 2012-07-18 at archive.today University of Michigan. Retrieved on July 31, 2009
  13. PMID 3167211
    .
  14. .
  15. ^ .
  16. ^ .
  17. ^ .
  18. ^ a b Drugbank.ca > Showing drug card for Retapamulin (DB01256) Update Date: 2009-06-23